Reply

Collaborators, Affiliations

VCD/ILO Delphi Steering Committee:
Anne E Vertigan, Vanessa M McDonald, Mark Hew, Malcolm Baxter, Debra Phyland, Thomas L Carroll, Hege Havstad Clemm, Maria Vollsæter, Ola Drange Røksund

¹ Monash Health, Melbourne, Victoria, Australia; Monash University, Melbourne, Victoria, Australia; Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia. Electronic address: paul.leong@monash.edu.
² Royal Brompton Hospital, London, United Kingdom.
³ John Hunter Hospital, Newcastle, Australia; Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia.
⁴ Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.
⁵ Monash Health, Melbourne, Victoria, Australia; Monash University, Melbourne, Victoria, Australia; Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia.

Comment

Paul Leong et al. J Allergy Clin Immunol. 2023 Dec.

. 2023 Dec;152(6):1688-1689.

doi: 10.1016/j.jaci.2023.08.027. Epub 2023 Sep 20.

VCD/ILO Delphi Steering Committee:
Anne E Vertigan, Vanessa M McDonald, Mark Hew, Malcolm Baxter, Debra Phyland, Thomas L Carroll, Hege Havstad Clemm, Maria Vollsæter, Ola Drange Røksund

¹ Monash Health, Melbourne, Victoria, Australia; Monash University, Melbourne, Victoria, Australia; Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia. Electronic address: paul.leong@monash.edu.
² Royal Brompton Hospital, London, United Kingdom.
³ John Hunter Hospital, Newcastle, Australia; Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia.
⁴ Department of Paediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway; Faculty of Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.
⁵ Monash Health, Melbourne, Victoria, Australia; Monash University, Melbourne, Victoria, Australia; Centre of Excellence in Treatable Traits, University of Newcastle, Newcastle, Australia.

No abstract available

Comment on

VCD and ILO are not synonymous.
Weinberger M. Weinberger M. J Allergy Clin Immunol. 2023 Dec;152(6):1687-1688. doi: 10.1016/j.jaci.2023.08.028. Epub 2023 Sep 20. J Allergy Clin Immunol. 2023. PMID: 37737750 No abstract available.